Fate Therapeutics宣布在2026年ASCO和EULAR年会上展示针对癌症与自身免疫性疾病的现货型CAR T细胞疗法管线

美股速递05-21

Fate Therapeutics Inc宣布，将在2026年美国临床肿瘤学会（ASCO）和欧洲抗风湿病联盟（EULAR）年度会议上，展示其针对癌症及自身免疫性疾病的现货型CAR T细胞疗法研发管线。这一系列报告将重点介绍公司在开发即用型细胞免疫疗法方面的最新进展与成果。

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/1167889454?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-05-21 20:30","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1167889454","market":"us","top_or_hot":-1,"title":"Fate Therapeutics宣布在2026年ASCO和EULAR年会上展示针对癌症与自身免疫性疾病的现货型CAR T细胞疗法管线","media":"美股速递","content":"<p>Fate Therapeutics Inc宣布，将在2026年美国临床肿瘤学会（ASCO）和欧洲抗风湿病联盟（EULAR）年度会议上，展示其针对癌症及自身免疫性疾病的现货型CAR T细胞疗法研发管线。这一系列报告将重点介绍公司在开发即用型细胞免疫疗法方面的最新进展与成果。</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Fate Therapeutics宣布在2026年ASCO和EULAR年会上展示针对癌症与自身免疫性疾病的现货型CAR T细胞疗法管线</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFate Therapeutics宣布在2026年ASCO和EULAR年会上展示针对癌症与自身免疫性疾病的现货型CAR T细胞疗法管线\n</h2>\n\n<h4 class=\"meta\">\n\n2026-05-21 20:30 北京时间&nbsp;&nbsp;&nbsp;<strong>美股速递</strong>\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Fate Therapeutics Inc宣布，将在2026年美国临床肿瘤学会（ASCO）和欧洲抗风湿病联盟（EULAR）年度会议上，展示其针对癌症及自身免疫性疾病的现货型CAR T细胞疗法研发管线。这一系列报告将重点介绍公司在开发即用型细胞免疫疗法方面的最新进展与成果。</p>\n\n<a href=\"\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"FATE","symbol_name":"Fate Therapeutics Inc","start_time":0,"source_url":"","article_id":"1167889454","we_media_id":"1004306016","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1167889454","pubTimestamp":1779366627,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"美股速递","introduction":"全球快讯第一时间播报","home_visible":1,"id":"1004306016","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"Fate Therapeutics Inc宣布，将在2026年美国临床肿瘤学会（ASCO）和欧洲抗风湿病联盟（EULAR）年度会议上，展示其针对癌症及自身免疫性疾病的现货型CAR T细胞疗法研发管线。这一系列报告将重点介绍公司在开发即用型细胞免疫疗法方面的最新进展与成果。","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"zh","relate_stocks":{"FATE":"Fate Therapeutics Inc","BK4139":"生物科技"},"translate_title":"Fate Therapeutics Announces Showcase of In-Stock CAR T Cell Therapy Pipeline for Cancer and Autoimmune Diseases at 2026 ASCO and EULAR Annual Meetings","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"FATE":1},"content_text":"Fate Therapeutics Inc宣布，将在2026年美国临床肿瘤学会（ASCO）和欧洲抗风湿病联盟（EULAR）年度会议上，展示其针对癌症及自身免疫性疾病的现货型CAR T细胞疗法研发管线。这一系列报告将重点介绍公司在开发即用型细胞免疫疗法方面的最新进展与成果。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":true,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.3","shortVersion":"4.42.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1167889454","isCrawlerRequest":true}